309
Participants
Start Date
February 26, 2013
Primary Completion Date
July 2, 2018
Study Completion Date
July 30, 2018
Capecitabine
Capecitabine, tablets for oral use, 1250 mg/m² twice daily for 2 weeks followed by one week rest (3-week-cycle) (locally supplied)
Exemestane
Exemestane, tablets for oral use, 25 mg per day in (locally supplied)
Everolimus
Everolimus, 5 mg tablets for oral use, 10 mg (2 x 5 mg) per day (centrally supplied)
Novartis Investigative Site, Jesus Maria
Novartis Investigative Site, Surquillo
Novartis Investigative Site, San Borja
Novartis Investigative Site, Hazmiyeh
Novartis Investigative Site, Saida
Novartis Investigative Site, Budapest
Novartis Investigative Site, Randwick
Novartis Investigative Site, Wahroonga
Novartis Investigative Site, Tatabánya
Novartis Investigative Site, Parkville
Novartis Investigative Site, Malvern
Novartis Investigative Site, Liège
Novartis Investigative Site, Roskilde
Novartis Investigative Site, Debrecen
Novartis Investigative Site, Vejle
Novartis Investigative Site, Rio Negro
Novartis Investigative Site, Lopburi
Novartis Investigative Site, Madrid
Novartis Investigative Site, Madrid
Florida Cancer Specialists Dept of Oncology (2), Fort Myers
Florida Cancer Specialists FL Cancer Specialists, Fort Myers
Novartis Investigative Site, Istanbul
Novartis Investigative Site, Izmir
Sarah Cannon Research Institute SC (2), Nashville
Chattanooga Oncology and Hematology Assoicates, PC Chattanooga Oncology, Chattanooga
The Jones Clinic SC, Germantown
Novartis Investigative Site, Muang
Novartis Investigative Site, Seville
Oncology Hematology Care Inc Oncology Hematology Care 2, Cincinnati
Novartis Investigative Site, Kuala Lumpur
Glacier View Research Institute - Cancer SC, Kalispell
Oklahoma Cancer Specialists and Research Institute Oklahoma Cancer Specialists, Tulsa
The Center for Cancer and Blood Disorders Dept. of The Ctr for C & BD, Fort Worth
Novartis Investigative Site, Kota Kinabalu
University of California at Los Angeles Mattel Children's Hospital, Los Angeles
Novartis Investigative Site, Songkhla
Sharp Memorial Hospital SharpClinicalOncologyResearch, San Diego
Northwest Medical Specialties Dept of Onc, Tacoma
Novartis Investigative Site, Moscow
Novartis Investigative Site, Arkhangelsk
Novartis Investigative Site, El Achrafiyé
Novartis Investigative Site, Saint Petersburg
Novartis Investigative Site, Pune
Lahey Clinic Dept of Lahey Clinic (2), Burlington
New England Hematology/ Oncology Associates, P.C. SC, Newton
Trinitas Comprehensive Cancer Center SC, Elizabeth
Hackensack University Medical Center Dept of Oncology, Hackensack
Rutgers-New Jersey Medical School SC, Newark
University of Tennessee SC, Knoxville
University of Virginia Health Systems SC-4, Charlottesville
Novartis Investigative Site, CABA
Novartis Investigative Site, Posadas
Novartis Investigative Site, Limerick
Novartis Investigative Site, Galway
Novartis Investigative Site, Beirut
Novartis Investigative Site, Arequipa
Novartis Investigative Site, Rosario
Novartis Investigative Site, Córdoba
Novartis Investigative Site, Salvador
Novartis Investigative Site, Natal
Novartis Investigative Site, Passo Fundo
Novartis Investigative Site, Porto Alegre
Novartis Investigative Site, São Paulo
Novartis Investigative Site, Aarhus
Novartis Investigative Site, Copenhagen
Novartis Investigative Site, Næstved
Novartis Investigative Site, Odense C
Novartis Investigative Site, Hyderabad
Novartis Investigative Site, Kolkata
Novartis Investigative Site, Mumbai
Novartis Investigative Site, Dublin
Novartis Investigative Site, Beirut
Novartis Investigative Site, Barcelona
Novartis Investigative Site, Eskilstuna
Novartis Investigative Site, Jönköping
Novartis Investigative Site, Stockholm
Novartis Investigative Site, Uppsala
Novartis Investigative Site, Vaxjo
Novartis Investigative Site, Västerås
Novartis Investigative Site, Adana
Novartis Investigative Site, East Kilbride
Novartis Investigative Site, Middlesbrough
Novartis Investigative Site, Nottingham
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY